I would love to know what the company plans are for securing DOE funding which requires matching funds. I don’t see it being part of a Capital raise with shareholders. That will need to be an institutional raise or loan. The amount needed is too large. In the mean time there is ample opportunity for the market cap to grow and even explode if Visalia etc are at full capacity and graphite price is profitable.
- Forums
- ASX - By Stock
- SYR
- General Discussion
General Discussion, page-1279
-
- There are more pages in this discussion • 388 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SYR (ASX) to my watchlist
|
|||||
Last
32.0¢ |
Change
-0.005(1.54%) |
Mkt cap ! $331.1M |
Open | High | Low | Value | Volume |
33.0¢ | 33.0¢ | 32.0¢ | $658.4K | 2.040M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 81000 | 32.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
32.5¢ | 119731 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 81000 | 0.320 |
12 | 862725 | 0.315 |
22 | 1020350 | 0.310 |
26 | 1008672 | 0.305 |
41 | 2517497 | 0.300 |
Price($) | Vol. | No. |
---|---|---|
0.325 | 119731 | 6 |
0.330 | 115790 | 5 |
0.335 | 216100 | 7 |
0.340 | 86315 | 5 |
0.345 | 116537 | 6 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
SYR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online